RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Radiopharm Theranostics Stock

Radiopharm Theranostics ROA 2024

Radiopharm Theranostics ROA

-0.67

Ticker

RAD.AX

ISIN

AU0000181851

In 2024, Radiopharm Theranostics's return on assets (ROA) was -0.67, a 82.45% increase from the -0.36 ROA in the previous year.

Radiopharm Theranostics Aktienanalyse

What does Radiopharm Theranostics do?

Radiopharm Theranostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Radiopharm Theranostics's Return on Assets (ROA)

Radiopharm Theranostics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Radiopharm Theranostics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Radiopharm Theranostics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Radiopharm Theranostics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Radiopharm Theranostics stock

What is the Return on Assets (ROA) of Radiopharm Theranostics this year?

The Return on Assets (ROA) of Radiopharm Theranostics is -0.67 undefined this year.

What was the ROA of Radiopharm Theranostics compared to the previous year?

The ROA of Radiopharm Theranostics has increased by 82.45% compared to the previous year.

What consequences do high ROA have for investors of Radiopharm Theranostics?

A high ROA is advantageous for investors of Radiopharm Theranostics, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Radiopharm Theranostics?

A low ROA can be unfavorable for investors of Radiopharm Theranostics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Radiopharm Theranostics affect the company?

An increase in ROA of Radiopharm Theranostics can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Radiopharm Theranostics impact the company?

A reduction in the ROA of Radiopharm Theranostics can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Radiopharm Theranostics?

Some factors that can influence the ROA of Radiopharm Theranostics include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Radiopharm Theranostics important for investors?

The ROA of Radiopharm Theranostics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Radiopharm Theranostics take to improve ROA?

To improve ROA, Radiopharm Theranostics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Radiopharm Theranostics pay?

Over the past 12 months, Radiopharm Theranostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Radiopharm Theranostics is expected to pay a dividend of 0 AUD.

What is the dividend yield of Radiopharm Theranostics?

The current dividend yield of Radiopharm Theranostics is .

When does Radiopharm Theranostics pay dividends?

Radiopharm Theranostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Radiopharm Theranostics?

Radiopharm Theranostics paid dividends every year for the past 0 years.

What is the dividend of Radiopharm Theranostics?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Radiopharm Theranostics located?

Radiopharm Theranostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Radiopharm Theranostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Radiopharm Theranostics from 11/17/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.

When did Radiopharm Theranostics pay the last dividend?

The last dividend was paid out on 11/17/2024.

What was the dividend of Radiopharm Theranostics in the year 2023?

In the year 2023, Radiopharm Theranostics distributed 0 AUD as dividends.

In which currency does Radiopharm Theranostics pay out the dividend?

The dividends of Radiopharm Theranostics are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Radiopharm Theranostics

Our stock analysis for Radiopharm Theranostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Radiopharm Theranostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.